ABEO
Abeona Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.45 / 10
Netural
Money flow analysis registers 7.62/10, showing robust fund flow characteristics. Positive momentum in Large is countered by negative tendencies in overall, block, Small, Medium, and Extra-large, suggesting positive flow conditions. Research analyst consensus shows overwhelmingly bullish analyst consensus, demonstrating strong conviction. Current ratings: Strong Buy(100.0%) across 1 coverage providers, supported by 3.28 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-13
InstitutionHC Wainwright & Co.
Times predicted5
Historical Win Rate40.0%
What is the market sentiment for ABEO?
- ABEO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.45/10 (Netural).
